Korean billionaire's fortune soars as his pharma stocks surge
String of licensing deals with global drugmakers gives Hanmi founder Lim Sung-ki a net worth of about US$2.7b
Seoul
THE South Korean man who founded two drug companies that are among Asia's best performing stocks for the past year is seeing his fortune climb after vaulting into the region's billionaire's club.
Hanmi Science Co has surged 971 per cent while its subsidiary Hanmi Pharmaceutical Co has gained 805 per cent over the last 12 months after a string of licensing deals with global drugmakers. The rally gave founder Lim Sung-ki a net worth of about US$2.7 billion as at Monday's close, according to the Bloomberg Billionaires index.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
HCA beats first-quarter profit estimates on higher patient admissions
US FDA approves Pfizer’s gene therapy for rare bleeding disorder
EU toughens rules on Chinese fashion retailer Shein
Best World under fire from shareholders at AGM over dividends, director salaries
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years
Sheng Siong Q1 net profit up 9.3% on higher revenue